Showing results (31-40 of 97) with videos related to

Sort By:
Pageof 10
Annals of the Rheumatic Diseases|December 18, 2013
Golimumab 3-year safety update: an analysis of pooled data from the long-term extensions of randomised, double-blind, placebo-controlled trials conducted in patients with rheumatoid arthritis, psoriatic arthritis or ankylosing spondylitisJonathan Kay, Roy Fleischmann, Edward Keystone, et al.
Arthritis and Rheumatism|October 31, 2009
Effect of certolizumab pegol with methotrexate on home and work place productivity and social activities in patients with active rheumatoid arthritisArthur Kavanaugh, Josef S Smolen, Paul Emery, et al.
Arthritis Care & Research|May 31, 2021
Identification of Distinct Disease Activity Trajectories in Methotrexate-Naive Patients With Rheumatoid Arthritis Receiving Tofacitinib Over Twenty-Four MonthsVivian P Bykerk, Eun Bong Lee, Ronald van Vollenhoven, et al.
ACR Open Rheumatology|November 29, 2019
Persistence of Tofacitinib in the Treatment of Rheumatoid Arthritis in Open-Label, Long-Term Extension Studies up to 9.5 YearsJanet E Pope, Edward Keystone, Shahin Jamal, et al.
Clinical Reviews in Allergy & Immunology|December 10, 2009
Advantages of multiplex proteomics in clinical immunology: the case of rheumatoid arthritis: novel IgXPLEX™: planar microarray diagnosisPeter Lea, Edward Keystone, Sasi Mudumba, et al.
Arthritis Care & Research|April 27, 2018
Tofacitinib in Rheumatoid Arthritis: Lack of Early Change in Disease Activity and the Probability of Achieving Low Disease Activity at Month 6Ronald F van Vollenhoven, Eun Bong Lee, Lara Fallon, et al.
Rheumatology (Oxford, England)|March 25, 2017
Benefit of biologics initiation in moderate versus severe rheumatoid arthritis: evidence from a United States registryArthur Kavanaugh, Edward Keystone, Jeffrey D Greenberg, et al.
Arthritis Research & Therapy|November 19, 2010
Association of serum markers with improvement in clinical response measures after treatment with golimumab in patients with active rheumatoid arthritis despite receiving methotrexate: results from the GO-FORWARD studySudha Visvanathan, Mahboob U Rahman, Edward Keystone, et al.
Annals of the Rheumatic Diseases|May 5, 2010
Continued inhibition of structural damage over 2 years in patients with rheumatoid arthritis treated with rituximab in combination with methotrexateStanley B Cohen, Edward Keystone, Mark C Genovese, et al.
Annals of the Rheumatic Diseases|August 7, 2013
Long-term safety and efficacy of certolizumab pegol in combination with methotrexate in the treatment of rheumatoid arthritis: 5-year results from the RAPID 1 trial and open-label extensionEdward Keystone, Robert Landewé, Ronald van Vollenhoven, et al.
Pageof 10